The safety profile of Haemophilus influenzae type b–Neisseria meningitidis serogroups C and Y tetanus toxoid conjugate vaccine (HibMenCY)

Stephen Rinderknecht Iowa Health Physicians; Waukee, IA USACorrespondence[email protected]

Kristina A. Bryant University of Louisville; Louisville, KY USA

Terry Nolan Murdoch Children’s Research Institute and University of Melbourne School of Population Health; Melbourne, VIC Australia

Noris Pavia-Ruz School of Medicine; Universidad Nacional Autonoma de Mexico; Mexico City, Mexico

Carlos Aranza Doniz Centro Medico Lic. Adolfo Lopez Mateos; Toluca, Mexico

Miguel Angel Rodriguez Weber Instituto Nacional de Pediatría; Coyoacan, México

Christopher Cohen GlaxoSmithKline Biologicals King of Prussia, PA USA

Emmanuel Aris GlaxoSmithKline Biologicals; Wavre, Belgium

Narcisa Mesaros GlaxoSmithKline Biologicals; Wavre, Belgium

Jacqueline M. Miller GlaxoSmithKline Biologicals King of Prussia, PA USA

Your download is now in progress and you may close this window